Methylprednisolone versus metoclopramide as antiemetic treatment in patients receiving adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) chemotherapy: a randomized crossover blind study. [electronic resource]
Producer: 19900315Description: 365-8 p. digitalISSN:- 1120-009X
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- drug therapy
- Cyclophosphamide -- adverse effects
- Female
- Fluorouracil -- adverse effects
- Humans
- Methotrexate -- adverse effects
- Methylprednisolone -- therapeutic use
- Metoclopramide -- therapeutic use
- Middle Aged
- Randomized Controlled Trials as Topic
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.